IL157475A0 - Synthetic vaccines comprising polyhydroxypolymer carriers - Google Patents
Synthetic vaccines comprising polyhydroxypolymer carriersInfo
- Publication number
- IL157475A0 IL157475A0 IL15747502A IL15747502A IL157475A0 IL 157475 A0 IL157475 A0 IL 157475A0 IL 15747502 A IL15747502 A IL 15747502A IL 15747502 A IL15747502 A IL 15747502A IL 157475 A0 IL157475 A0 IL 157475A0
- Authority
- IL
- Israel
- Prior art keywords
- polyhydroxypolymer
- carriers
- synthetic vaccines
- vaccines
- synthetic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0007—Nervous system antigens; Prions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6068—Other bacterial proteins, e.g. OMP
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6087—Polysaccharides; Lipopolysaccharides [LPS]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6093—Synthetic polymers, e.g. polyethyleneglycol [PEG], Polymers or copolymers of (D) glutamate and (D) lysine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/64—Medicinal preparations containing antigens or antibodies characterised by the architecture of the carrier-antigen complex, e.g. repetition of carrier-antigen units
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Psychology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/785,215 US7135181B2 (en) | 2000-02-21 | 2001-02-20 | Method for down-regulation of amyloid |
DKPA200101231 | 2001-08-20 | ||
US33754301P | 2001-10-22 | 2001-10-22 | |
PCT/DK2002/000112 WO2002066056A2 (en) | 2001-02-19 | 2002-02-19 | Synthetic vaccines comprising polyhydroxypolymer carriers |
Publications (1)
Publication Number | Publication Date |
---|---|
IL157475A0 true IL157475A0 (en) | 2004-03-28 |
Family
ID=35160895
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL15747502A IL157475A0 (en) | 2001-02-20 | 2002-02-19 | Synthetic vaccines comprising polyhydroxypolymer carriers |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1363664A2 (zh) |
JP (1) | JP2004529881A (zh) |
CN (1) | CN100562338C (zh) |
AU (1) | AU2002233166B2 (zh) |
CA (1) | CA2440197A1 (zh) |
IL (1) | IL157475A0 (zh) |
NO (1) | NO335602B1 (zh) |
NZ (1) | NZ527720A (zh) |
WO (1) | WO2002066056A2 (zh) |
ZA (1) | ZA200400895B (zh) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2498739A1 (en) * | 2002-09-12 | 2004-03-25 | Pharmexa A/S | Immunization against autologous ghrelin |
US20070014807A1 (en) * | 2003-09-03 | 2007-01-18 | Maida Anthony E Iii | Multiplex vaccine |
WO2005046605A2 (en) * | 2003-11-07 | 2005-05-26 | University Of Rochester | Compositions and methods of treating neurological diseases |
WO2012125567A2 (en) * | 2011-03-11 | 2012-09-20 | Flow Pharma Inc. | Vaccine formulation of mannose coated peptide particles |
CN103665113A (zh) * | 2012-09-14 | 2014-03-26 | 深圳市安群生物工程有限公司 | 人Aβ42抗原决定簇多肽、抗原、抗体、用途及试剂盒 |
RU2635517C1 (ru) * | 2016-09-14 | 2017-11-13 | Закрытое акционерное общество "Институт фармацевтических технологий" (ЗАО "ИФТ") | Синтетический иммуноген для защиты и лечения от зависимости от психоактивных веществ |
CN112165956A (zh) * | 2018-04-10 | 2021-01-01 | Ac免疫有限公司 | 抗Aβ治疗性疫苗 |
CA3095983A1 (en) | 2018-04-10 | 2019-10-17 | Ac Immune Sa | Anti-abeta therapeutic vaccines |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ249704A (en) * | 1992-02-11 | 1996-11-26 | Jackson H M Found Military Med | A two carrier immunogenic construct comprising a 70+ kd molecule conjugated to at least 1 t-dependent antigen, preparation, compositions containing the construct |
AU4377793A (en) * | 1992-05-20 | 1993-12-13 | Johns Hopkins University, The | Alternative receptor therapy |
HUP0103976A3 (en) * | 1998-10-05 | 2008-04-28 | Pharmexa As | Novel methods for therapeutic vaccination |
-
2002
- 2002-02-19 AU AU2002233166A patent/AU2002233166B2/en not_active Ceased
- 2002-02-19 NZ NZ527720A patent/NZ527720A/en unknown
- 2002-02-19 WO PCT/DK2002/000112 patent/WO2002066056A2/en active IP Right Grant
- 2002-02-19 EP EP02700174A patent/EP1363664A2/en not_active Withdrawn
- 2002-02-19 CA CA002440197A patent/CA2440197A1/en not_active Abandoned
- 2002-02-19 JP JP2002565614A patent/JP2004529881A/ja active Pending
- 2002-02-19 IL IL15747502A patent/IL157475A0/xx unknown
- 2002-08-20 CN CNB028163265A patent/CN100562338C/zh not_active Expired - Fee Related
-
2004
- 2004-01-30 NO NO20040431A patent/NO335602B1/no not_active IP Right Cessation
- 2004-02-03 ZA ZA200400895A patent/ZA200400895B/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN1893970A (zh) | 2007-01-10 |
WO2002066056A3 (en) | 2003-01-03 |
CN100562338C (zh) | 2009-11-25 |
EP1363664A2 (en) | 2003-11-26 |
NO335602B1 (no) | 2015-01-12 |
ZA200400895B (en) | 2005-05-03 |
CA2440197A1 (en) | 2002-08-29 |
JP2004529881A (ja) | 2004-09-30 |
WO2002066056A8 (en) | 2004-04-29 |
AU2002233166B2 (en) | 2006-06-29 |
NZ527720A (en) | 2005-03-24 |
NO20040431L (no) | 2004-04-16 |
WO2002066056A2 (en) | 2002-08-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0402067A3 (en) | Vaccines | |
HUP0402259A3 (en) | Vaccines | |
HUP0402471A3 (en) | Vaccine | |
GB0407935D0 (en) | Vaccine | |
HUP0303372A3 (en) | Vaccine | |
EP1423141A4 (en) | VACCINE | |
GB0306611D0 (en) | Novel vaccine | |
GB0121171D0 (en) | Vaccine | |
EP1419268A4 (en) | SECRETION CONTROL ARTICLE | |
IL157475A0 (en) | Synthetic vaccines comprising polyhydroxypolymer carriers | |
GB0105238D0 (en) | Vaccines | |
GB0108534D0 (en) | Retaining means | |
ZA200306422B (en) | Synthetic vaccines comprising polyhydroxypolymer carriers. | |
GB0004533D0 (en) | Vaccines | |
GB0117453D0 (en) | Carrier | |
GB2376939B (en) | Retaining means | |
GB0113275D0 (en) | Fishing-tackle article | |
GB0113552D0 (en) | Vaccines | |
CA91868S (en) | Pet carrier | |
GB0006281D0 (en) | Vaccines | |
GB0014280D0 (en) | Vaccines | |
GB0110960D0 (en) | Improved carrier | |
GB0102133D0 (en) | Improved carrier | |
CA91465S (en) | Article carrier | |
GB0112279D0 (en) | Retaining article |